Literature DB >> 24515659

Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis.

Edoardo Rosato1, Biagio Barbano, Antonietta Gigante, Ilenia Molinaro, Silvia Quarta, Simonetta Pisarri, Antonio Amoroso, Rosario Cianci, Felice Salsano.   

Abstract

OBJECTIVE: Patients with systemic sclerosis (SSc; scleroderma) are at high risk for the development of ischemic digital ulcers (DUs), which occur in 35-60% of SSc patients. The aim of this study was to assess the correlation between intrarenal arterial stiffness and DUs in SSc patients and to evaluate the prognostic value of Doppler indices to predict new DU occurrence.
METHODS: Seventy unselected, consecutive patients with SSc (58 women and 12 men, mean ± SD age 49.5 ± 13.8 years) were enrolled. In all patients, Doppler ultrasound examination was performed. The following Doppler indices of intrarenal stiffness were measured: peak systolic velocity (PSV), end diastolic velocity (EDV), resistive index (RI), pulsatile index (PI), and systolic/diastolic ratio (S/D).
RESULTS: In total, 30 (42%) of 70 patients experienced new DUs. RI, S/D, and PI were significantly higher in SSc patients with new DUs than in SSc patients without new DUs. The receiver operating characteristic (ROC) curves demonstrated a good accuracy of new DU prediction for RI (0.94, P < 0.0001), S/D (0.92, P < 0.0001), and PI (0.88, P < 0.0001). Conversely, the ROC curve showed no performance for PSV (0.58, P > 0.05) and EDV (0.28, P > 0.05). Using a cutoff value of 0.70 for RI and 3.25 for S/D, the positive predictive value was 90.6% and 92.9%, respectively.
CONCLUSION: We can conclude that Doppler indices of intrarenal stiffness are reliable markers of new DU occurrence. Doppler indices could be used in association with the capillaroscopic and clinical findings or serologic tests for the identification of patients at high risk of developing DUs.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24515659     DOI: 10.1002/acr.22309

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  6 in total

Review 1.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

2.  Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: Correlation with histological findings.

Authors:  Antonietta Gigante; Biagio Barbano; Francesca Di Mario; Edoardo Rosato; Marzia Simonelli; Anna Rachele Rocca; Fabrizio Conti; Fulvia Ceccarelli; Konstantinos Giannakakis; Guido Valesini; Rosario Cianci
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-18       Impact factor: 3.219

3.  Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Authors:  Antonietta Gigante; Giuseppe Barilaro; Biagio Barbano; Antonella Romaniello; Francesca Di Mario; Silvia Quarta; Maria Ludovica Gasperini; Gianluca Di Lazzaro Giraldi; Alessandro Laviano; Antonio Amoroso; Rosario Cianci; Edoardo Rosato
Journal:  Cardiorenal Med       Date:  2016-01-23       Impact factor: 2.041

4.  Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis.

Authors:  Shefali Khanna Sharma; Arghya Chattopadhyay; Siddharth Jain; Chitra Raj Sharma; Debashish Mishra; Manish Rathi; Mahesh Prakash; Sanjay Jain
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

5.  Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis.

Authors:  Chiara Pellicano; Giorgia Leodori; Amalia Colalillo; Luca Navarini; Antonietta Gigante; Edoardo Rosato
Journal:  Clin Exp Med       Date:  2021-08-30       Impact factor: 5.057

6.  CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis.

Authors:  Marcella Visentini; Chiara Pellicano; Giorgia Leodori; Ramona Marrapodi; Stefania Colantuono; Antonietta Gigante; Milvia Casato; Edoardo Rosato
Journal:  Clin Exp Immunol       Date:  2021-06-06       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.